BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28457197)

  • 1. Management of cardiovascular risk in systemic lupus erythematosus: a systematic review.
    Andrades C; Fuego C; Manrique-Arija S; Fernández-Nebro A
    Lupus; 2017 Nov; 26(13):1407-1419. PubMed ID: 28457197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus.
    Wierzbicki AS
    Lupus; 2000; 9(3):194-201. PubMed ID: 10805487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Impact of Statins on the Lipid Profile and Cardiovascular Risk in Patients With Systemic Lupus Erythematosus: Systematic Review of the Literature and a Meta-analysis.
    Sánchez P; Toro-Trujillo E; Muñoz-Velandia OM; García AA; Fernández-Ávila DG
    Reumatol Clin (Engl Ed); 2019; 15(6):e86-e91. PubMed ID: 29428197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
    Fasano S; Margiotta DP; Navarini L; Pierro L; Pantano I; Riccardi A; Afeltra A; Valentini G
    Lupus; 2017 Dec; 26(14):1463-1472. PubMed ID: 28786768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
    Arnaud L; Mathian A; Bruckert E; Amoura Z
    Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.
    Benvenuti F; Gatto M; Larosa M; Iaccarino L; Punzi L; Doria A
    Expert Opin Drug Saf; 2015; 14(9):1373-85. PubMed ID: 26212119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
    J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis in systemic lupus erythematosus.
    Croca S; Rahman A
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):364-372. PubMed ID: 29224678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention.
    Thomas GN; Tam LS; Tomlinson B; Li EK
    Hong Kong Med J; 2002 Feb; 8(1):26-32. PubMed ID: 11861990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.
    Wu LS; Tang CH; Lin YS; Lin CP; Hung ST; Hwa HL; Luo SF; Chu PH
    Am J Med Sci; 2014 Jan; 347(1):42-9. PubMed ID: 23255242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
    Ruiz-Irastorza G; Ramos-Casals M; Brito-Zeron P; Khamashta MA
    Ann Rheum Dis; 2010 Jan; 69(1):20-8. PubMed ID: 19103632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].
    Arnaud L; Mathian A; Adoue D; Bader-Meunier B; Baudouin V; Belizna C; Bonnotte B; Boumedine F; Chaib A; Chauchard M; Chiche L; Daugas E; Ghali A; Gobert P; Gondran G; Guettrot-Imbert G; Hachulla E; Hamidou M; Haroche J; Hervier B; Hummel A; Jourde-Chiche N; Korganow AS; Kwon T; Le Guern V; Le Quellec A; Limal N; Magy-Bertrand N; Marianetti-Guingel P; Martin T; Martin Silva N; Meyer O; Miyara M; Morell-Dubois S; Ninet J; Papo T; Pennaforte JL; Polomat K; Pourrat J; Queyrel V; Raymond I; Remy P; Sacre K; Schmidt J; Sibilia J; Viallard JF; Viau Brabant A; Wahl D; Bruckert E; Amoura Z;
    Rev Med Interne; 2015 Jun; 36(6):372-80. PubMed ID: 25455954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review.
    Kirchler C; Husar-Memmer E; Rappersberger K; Thaler K; Fritsch-Stork R
    Autoimmun Rev; 2021 May; 20(5):102794. PubMed ID: 33722754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
    Ballocca F; D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Barbero U; Abbate A; Bertero MT; Zoccai GB; Gaita F
    Eur J Prev Cardiol; 2015 Nov; 22(11):1435-41. PubMed ID: 25139772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus.
    Cypienė A; Dadonienė J; Rugienė R; Ryliškytė L; Kovaitė M; Petrulionienė Z; Venalis A; Laucevičius A
    Medicina (Kaunas); 2010; 46(8):522-30. PubMed ID: 20966628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis.
    Munguía-Realpozo P; Mendoza-Pinto C; García-Carrasco M; Berra-Romani R; Sierra-Benito C; Méndez-Martínez S; Cervera R
    Autoimmun Rev; 2021 Sep; 20(9):102887. PubMed ID: 34237422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of cardiovascular disease in systemic lupus erythematosus.
    Aranow C; Ginzler EM
    Lupus; 2000; 9(3):166-9. PubMed ID: 10805482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.